Acute decompensated heart failure: The cardiorenal syndrome

Cleveland Clinic Journal of Medicine

Volumn 73, Issue SUPPL.2, 2006, Pages

  Francis, Gary ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; FUROSEMIDE;

ACUTE DISEASE; CONGESTIVE HEART FAILURE; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; PROGNOSIS; REVIEW; SYNDROME;

ACUTE DISEASE; DISEASE PROGRESSION; DIURETICS; FUROSEMIDE; GLOMERULAR FILTRATION RATE; HEART FAILURE, CONGESTIVE; HUMANS; PROGNOSIS; RENAL INSUFFICIENCY; SYNDROME;

EID: 33746496834     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.73.Suppl_2.S8     Document Type: Article

References (29)

1. Gottlieb SS, Abraham W, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 2002; 8:136-141.
2. ADHERE™ (Acute Decompensated Heart Failure National Registry). Third quarter 2004 National Benchmark Report. Available at: www.adhereregistry.com/nat.html. Accessed April 26, 2006.
3. Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000; 102:203-210.
4. Mezu UL, Philip K, Francis GS, Starling RC, Taylor DO, Tang WHW. The impact of baseline glomerular filtration rate on the incidence of worsening renal failure in patients admitted for acute decompensated heart failure. J Am Coll Cardiol 2005; 45(Suppl 3A). Abstract 1133-178.
5. Mahon NG, Blackstone EH, Francis GS, Starling RC 3rd, Young JB, Lauer MS. The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol 2002; 40:1106-1113.
6. Gottlieb SS, Brater DC, Thomas I, et al. BG9717 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 2002; 105:1348-1353.
7. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med 1985; 103:1-6.
8. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987; 57:17-22.
9. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC, ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006; 47:76-84.
10. Brater DC. Diuretic therapy. N Engl J Med 1998; 339:387-395.
11. Wang DJ, Dowling TC, Meadows D, et al. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation 2004; 110:1620-1625.
12. Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 2005; 111:1487-1491.
13. Fauchald P, Forfang K, Amlie J. An evaluation of ultrafiltration as treatment of therapy-resistant cardiac edema. Acta Med Scand 1986; 219:47-52.
14. Rimondini A, Cipolla CM, Della Bella P, et al. Hemofiltration as short-term treatment for refractory congestive heart failure. Am J Med 1987; 83:43-48.
15. Agostoni PG, Marenzi GC, Pepi M, et al. Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 1993; 21:424-431.
16. Pepi M, Marenzi GC, Agostoni PG, et al. Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: pathophysiological correlates. Br Heart J 1993; 70:135-140.
17. Agostoni P, Marenzi G, Lauri G, et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am J Med 1994; 96:191-199.
18. Canaud B, Leblanc M, Leray-Moragues H, Delmas S, Klouche K, Beraud J-J. Slow continuous and daily ultrafiltration for refractory congestive heart failure. Nephrol Dial Transplant 1998; 13(Suppl 4):51-55.
19. Marenzi G, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni P. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 2001; 38:963-968.
20. Jaski BE, Miller D. Ultrafiltration in decompensated heart failure. Curr Heart Fail Rep 2005; 2:148-154.
21. Raman JS, Hata M, Bellomo R, Kohchi K, Cheung HL, Buxton BF. Hemofiltration during cardiopulmonary bypass for high risk adult cardiac surgery. Int J Artif Organs 2003; 26:753-757.
22. Saltzberg MT. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure. Rev Cardiovasc Med 2004; 5(Suppl 4):S17-S27.
23. Sheppard R, Panyon J, Pohwani AL, et al. Intermittent outpatient ultrafiltration for the treatment of severe refractory congestive heart failure. J Card Fail 2004; 10:380-383.
24. Bart BA, Boyle A, Bank AJ, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPIDCHF) trial. J Am Coll Cardiol 2005; 46:2043-2046.
25. Costanzo MR, Saltzberg M, O'Sullivan J, Sobotka P. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol 2005; 46:2047-2051.
26. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004; 109:1004-1009.
27. Costanza MR. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. Presented at the 55th Annual Scientific Session of the American College of Cardiology; March 13, 2006; Atlanta, GA.
28. Grube E, Teirstein P, Baim D, Mueller R, Schmid T, Burkhoff D. Intrarenal fenoldopam increases renal artery flow velocity and causes fewer effects on blood pressure lowering than intravenous fenoldopam. Am J Cardiol 2004; 94(Suppl 6A):176E.
29. Madyoon H, Teirstein P, Baim D, Croushore L, Anderson E, Mathur V. Differential effects between intravenous and local renal delivery of fenoldopam on renal function and blood pressure: a randomized, controlled trial. Am J Cardiol 2004; 94(Suppl 6A): 22E-23E.